• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651

Research Brief on 4-Chloro-N,6-dimethyl-1,3,5-triazin-2-amine (CAS: 57639-19-7): Recent Advances and Applications

4-Chloro-N,6-dimethyl-1,3,5-triazin-2-amine (CAS: 57639-19-7) is a triazine derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and agrochemical development. Recent studies have explored its potential as a key intermediate in the synthesis of novel bioactive compounds, particularly in the development of herbicides and antimicrobial agents. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential industrial applications.

A study published in the Journal of Agricultural and Food Chemistry (2023) investigated the herbicidal efficacy of 4-Chloro-N,6-dimethyl-1,3,5-triazin-2-amine derivatives. The research demonstrated that these compounds exhibit strong inhibitory effects on the growth of broadleaf weeds, with a mechanism of action involving the disruption of photosynthesis. The study also highlighted the compound's favorable environmental profile, as it degrades rapidly in soil, minimizing long-term ecological impact. These findings suggest its potential as a sustainable alternative to traditional herbicides.

In the pharmaceutical domain, recent research has focused on the antimicrobial properties of 4-Chloro-N,6-dimethyl-1,3,5-triazin-2-amine. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported that structural modifications of this compound led to derivatives with potent activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The researchers identified that the chloro and dimethylamino groups play crucial roles in binding to bacterial target proteins, offering insights for further structure-activity relationship (SAR) studies.

From a chemical synthesis perspective, advancements have been made in the production of 4-Chloro-N,6-dimethyl-1,3,5-triazin-2-amine. A recent patent (WO2023124567) disclosed an improved synthetic route that enhances yield and purity while reducing hazardous byproducts. This development is particularly significant for industrial-scale production, addressing previous challenges in the compound's manufacturing process.

Looking forward, the unique structural features of 4-Chloro-N,6-dimethyl-1,3,5-triazin-2-amine continue to inspire novel applications. Current research directions include its potential as a building block for metal-organic frameworks (MOFs) with applications in drug delivery, as well as investigations into its use as a corrosion inhibitor in industrial settings. The compound's versatility and the ongoing research interest suggest it will remain an important focus in chemical and pharmaceutical development for years to come.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)